Celltrion releases biosimilar Vegzelma in U.S.
Celltrion Healthcare, a Korean pharmaceuticals company, said Monday that it has launched its anti-cancer biosimilar Vegzelma in the United States. The bevacizumab treatment, a biosimilar referencing Genentech's Avastin, received...